Demethylation of Urokinase Promoter as a Prognostic Marker in Patients With Breast Carcinoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-03-0545
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Eosinopenia as a Prognostic Marker in Patients With Peritonitis

ISRN Infectious Diseases
2013English

P53 Expression as a Prognostic Marker in Inflammatory Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

Promoter Methylation of TRIM9 as a Marker for Detection of Circulating Tumor DNA in Breast Cancer Patients

SpringerPlus
Multidisciplinary
2015English

Platelet Count as a Prognostic Marker in Patients With Acute Coronary Syndromes

Circulation Journal
MedicineCardiovascular MedicineCardiology
2012English

SETD3 Acts as a Prognostic Marker in Breast Cancer Patients and Modulates the Viability and Invasion of Breast Cancer Cells

Scientific Reports
Multidisciplinary
2020English

LRAT Promoter Hypermethylation as a Prognostic Marker for Colorectal Cancer Impairs Retinol Metabolism

Journal of Clinical Gastroenterology and Treatment
2017English

SAC3D1: A Novel Prognostic Marker in Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2018English

P53 as a Prognostic Marker Associated With the Risk of Mortality for Oral Squamous Cell Carcinoma

Oncology Letters
Cancer ResearchOncology
2016English

Lrig1 Is a Positive Prognostic Marker in Hepatocellular Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy